These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31480611)

  • 21. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
    Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
    Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum paraoxonase activity decreases in rheumatoid arthritis.
    Tanimoto N; Kumon Y; Suehiro T; Ohkubo S; Ikeda Y; Nishiya K; Hashimoto K
    Life Sci; 2003 May; 72(25):2877-85. PubMed ID: 12697270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs.
    Rossi G; Kuleš J; Rafaj RB; Mrljak V; Lauzi S; Giordano A; Paltrinieri S
    Res Vet Sci; 2014 Oct; 97(2):318-24. PubMed ID: 25104322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers.
    González FEM; Ponce-RuÍz N; Rojas-GarcÍa AE; Bernal-Hernández YY; Mackness M; Ponce-Gallegos J; Cardoso-Saldaña G; Jorge-Galarza E; Torres-Tamayo M; Medina-Díaz IM
    Arch Med Sci Atheroscler Dis; 2019; 4():e47-e54. PubMed ID: 31211270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
    Mogarekar MR; Kulkarni SK
    Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase 1 Activity and Survival in Sepsis Patients.
    İnal V; Yamanel L; Taşkın G; Tapan S; Cömert B
    Balkan Med J; 2015 Apr; 32(2):183-8. PubMed ID: 26167343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity.
    Tomás M; Sentí M; Elosua R; Vila J; Sala J; Masià R; Marrugat J
    Eur J Pharmacol; 2001 Dec; 432(2-3):121-8. PubMed ID: 11740946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.